Cognitive function in patients with chronic lymphocytic leukemia: a cross-sectional study examining effects of disease and treatment
AnnaLynn M. Williams(University of Rochester), Michelle C. Janelsins(University of Rochester), Miriam T. Weber(University of Rochester), Charles E. Heckler(University of Rochester Medicine), Paul M. Barr(University of Rochester Medical Center), Clive S. Zent(University of Rochester Medical Center), Edwin van Wijngaarden(University of Ulster), Christopher L. Seplaki(University of Rochester)
Cited by 22
Related Papers
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
|Nature Medicine|2015|1.1k
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
Frailty in Older Adults: A Nationally Representative Profile in the United States
|The Journals of Gerontology Series A|2015|789